Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hires Gabriel Barbosa as Scientific Projects and Regulatory Developing Analyst

Medical Marijuana, Inc. (“the Company”) (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary HempMeds® Brasil has hired Gabriel Barbosa, MSc as the Company’s Scientific Projects and Regulatory Developing Analyst.

Related posts

Global Hemp Group, Inc. Pursuing Opportunities in America’s ‘New Billion-Dollar Crop’

Editor

Global Alliance for Cannabis Commerce Announces New President

CCT IMPACT Agent

Harborside Inc. Announces Second Quarter and First Half 2019 Results

CCT IMPACT Agent

Leave a Comment

%d bloggers like this: